ArticleFrontiers in cell and developmental biology2022

Construction and Validation of a 15-Top-prognostic-gene-based Signature to Indicate the Dichotomized Clinical Outcome and Response to Targeted Therapy for Bladder Cancer Patients.

Hongbing Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.